Mechanisms of EGFR Resistance in Glioblastoma

por Pan, Peter C., Magge, Rajiv S.
Publicado 2020

CATO: The Clone Alignment Tool

por Henstock, Peter V., LaPan, Peter
Publicado 2016

Impact of image segmentation on high-content screening data quality for SK-BR-3 cells

por Hill, Andrew A, LaPan, Peter, Li, Yizheng, Haney, Steve
Publicado 2007

Single cell cytometry of protein function in RNAi treated cells and in native populations

por LaPan, Peter, Zhang, Jing, Pan, Jing, Hill, Andrew, Haney, Steven A
Publicado 2008

Current usage of tumor treating fields for glioblastoma

por Lassman, Andrew B, Joanta-Gomez, Adela E, Pan, Peter C, Wick, Wolfgang
Publicado 2020

Optimization of total protein and activity assays for the detection of MMP-12 in induced human sputum

por LaPan, Peter, Brady, Jeff, Grierson, Christal, Fleming, Margaret, Miller, Doug, Sypek, Joe, Fu, Bin
Publicado 2010

Healthcare in schizophrenia: effectiveness and progress of a redesigned care network

por Tzeng, Dong-Sheng, Lian, Li-Chiu, Chang, Chin-Un, Yang, Chun-Yuh, Lee, Gian-Tin, Pan, Peter, Lung, For-Wey
Publicado 2007

Low Incidence of Opioid-Induced Respiratory Depression Observed with Oliceridine Regardless of Age or Body Mass Index: Exploratory Analysis from a Phase 3 Open-Label Trial in Posts...

por Brzezinski, Marek, Hammer, Gregory B., Candiotti, Keith A., Bergese, Sergio D., Pan, Peter H., Bourne, Michael H., Michalsky, Cathy, Wase, Linda, Demitrack, Mark A., Habib, Ashraf S.
Publicado 2021

ATHENA: A Phase 3, Open-Label Study Of The Safety And Effectiveness Of Oliceridine (TRV130), A G-Protein Selective Agonist At The µ-Opioid Receptor, In Patients With Moderate To Se...

por Bergese, Sergio D, Brzezinski, Marek, Hammer, Gregory B, Beard, Timothy L, Pan, Peter H, Mace, Sharon E, Berkowitz, Richard D, Cochrane, Kristina, Wase, Linda, Minkowitz, Harold S, Habib, Ashraf S
Publicado 2019

Outcomes following upfront radiation versus monitoring in atypical meningiomas: 16-year experience at a tertiary medical center

por Pan, Peter C, Pisapia, David J, Ramakrishna, Rohan, Schwartz, Theodore H, Pannullo, Susan C, Knisely, Jonathan P S, Chiang, Gloria C, Ivanidze, Jana, Stieg, Philip E, Liechty, Benjamin, Brandmaier, Andrew, Fine, Howard A, Magge, Rajiv S
Publicado 2021

Development of PF-06671008, a Highly Potent Anti-P-cadherin/Anti-CD3 Bispecific DART Molecule with Extended Half-Life for the Treatment of Cancer

por Root, Adam R., Cao, Wei, Li, Bilian, LaPan, Peter, Meade, Caryl, Sanford, Jocelyn, Jin, Macy, O’Sullivan, Cliona, Cummins, Emma, Lambert, Matthew, Sheehan, Alfredo D., Ma, Weijun, Gatto, Scott, Kerns, Kelvin, Lam, Khetemenee, D’Antona, Aaron M., Zhu, Lily, Brady, William A., Benard, Susan, King, Amy, He, Tao, Racie, Lisa, Arai, Maya, Barrett, Dianah, Stochaj, Wayne, LaVallie, Edward R., Apgar, James R., Svenson, Kristine, Mosyak, Lidia, Yang, Yinhua, Chichili, Gurunadh R., Liu, Liqin, Li, Hua, Burke, Steve, Johnson, Syd, Alderson, Ralph, Finlay, William J. J., Lin, Laura, Olland, Stéphane, Somers, William, Bonvini, Ezio, Gerber, Hans-Peter, May, Chad, Moore, Paul A., Tchistiakova, Lioudmila, Bloom, Laird
Publicado 2016